Invention Grant
- Patent Title: EML4-ALK translocations in lung cancer
-
Application No.: US14928347Application Date: 2015-10-30
-
Publication No.: US09957573B2Publication Date: 2018-05-01
- Inventor: Heather R. Sanders , Maher Albitar , Aurelia Meloni-Ehrig
- Applicant: Quest Diagnostics Investments Incorporated
- Applicant Address: US DE Wilmington
- Assignee: QUEST DIAGNOSTICS INVESTMENTS INCORPORATED
- Current Assignee: QUEST DIAGNOSTICS INVESTMENTS INCORPORATED
- Current Assignee Address: US DE Wilmington
- Agency: Foley & Lardner LLP
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; C12Q1/68 ; C07K16/40 ; C12Q1/48
Abstract:
The present disclosure relates to methods for the diagnosis and evaluation of neoplastic disorders, particularly non-small cell lung cancer. Assays are described in which patient test samples are analyzed for the presence of one or more specific EML4-ALK fusion genes associated with neoplastic disorders.
Public/Granted literature
- US20160160289A1 EML4-ALK TRANSLOCATIONS IN LUNG CANCER Public/Granted day:2016-06-09
Information query
